In The News
Test
Test
I’m afraid AI can’t do that: Law firms say smart tech uses limited
Holden dealers reject GM’s bleak alternate reality in class action
Lawyer’s defamation case fails serious harm test, judge finds
Nine, News Corp defeat defamation suits over Central Coast crime coverage
Zip offered Firstmac $4M to settle trade mark suit
High Court rejects Qantas appeal in ground crew sacking case
High Court to rule on reach of workplace law in high-stakes Qantas case
Mosaic Brands boss told GM paying $275K bonus would land him in jail, suit says

Veterinary pharmaceutical companies Norbrook Laboratories and Merial have launched twin appeals of two IP Australia decisions allowing Bayer to amend a proposed patent for a treatment for mammary gland infections.

Subscribe to Lawyerly to access this article.

Already a subscriber?
Lost your password?

For information on rights and reprints, contact subscriptions@lawyerly.com.au